United States · FDA National Drug Code directory
Omeprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-002_4cc78adf-d6a3-47b6-bc25-9d3f28d2a27a
- Product NDC
- 59651-002
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Omeprazole
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150819
- Source listing expiry
- 20261231
Source-listed ingredients
- OMEPRAZOLE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-002-01) · 59651-002-01
- 3 BLISTER PACK in 1 CARTON (59651-002-03) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (59651-002-10) · 59651-002-03
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-002-05) · 59651-002-05
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-002-30) · 59651-002-30
- 10 BLISTER PACK in 1 CARTON (59651-002-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (59651-002-10) · 59651-002-78
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-002-90) · 59651-002-90
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-002-99) · 59651-002-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →